Atlas Trials

Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

Clinical trial NCT06291064 · RECRUITING

Trial details

NCT number
NCT06291064
Sponsor
University of Chicago
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2025-03-18
Primary completion
2029-06-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.